Teva Pharmaceutical Industries Ltd ADR buy UBS Group AG
Start price
27.11.23
/
50%
€8.94
Target price
27.11.24
€11.87
Performance (%)
68.90%
Price
10.05.24
€15.10
Summary
This prediction is currently active. With a performance of 68.90% the BUY prediction by UBS_Group_AG is a big success. This prediction currently runs until 27.11.24. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Teva Pharmaceutical Industries Ltd ADR | 16.154% | 16.154% |
iShares Core DAX® | 4.094% | 3.543% |
iShares Nasdaq 100 | 1.424% | 0.512% |
iShares Nikkei 225® | -1.572% | -4.633% |
iShares S&P 500 | 1.822% | 0.963% |
Comments by UBS_Group_AG for this prediction
In the thread Teva Pharmaceutical Industries Ltd ADR diskutieren
Teva Pharmaceutical Industries Limited (NYSE: TEVA) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating. They now have a $13.00 price target on the stock, up previously from $11.00.
Ratings data for TEVA provided by MarketBeat